Adaptive Biotechnologies Corp Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VIKING GLOBAL INVESTORS LP | 02/17/2026 | 29.99 M | $487.10 M | 0.00% | 19.59% |
| BLACKROCK, INC. | 02/12/2026 | 13.33 M | $216.54 M | -0.18% | 8.71% |
| VANGUARD GROUP INC | 01/29/2026 | 11.28 M | $183.22 M | 0.06% | 7.37% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/17/2026 | 4.39 M | $71.25 M | 303.35% | 2.87% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 02/11/2026 | 4.06 M | $65.94 M | 100.00% | 2.68% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 3.51 M | $57.04 M | 3.26% | 2.29% |
| STATE STREET CORP | 02/13/2026 | 3.18 M | $51.67 M | 3.32% | 2.08% |
| LORD, ABBETT & CO. LLC | 02/13/2026 | 3.08 M | $50.03 M | 151.20% | 2.03% |
| INVESCO LTD. | 02/19/2026 | 3.11 M | $50.47 M | 248.76% | 2.03% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 2.90 M | $47.13 M | 54.39% | 1.90% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 02/17/2026 | 2.76 M | $44.83 M | -8.59% | 1.80% |
| JENNISON ASSOCIATES LLC | 01/30/2026 | 2.67 M | $43.44 M | 103.94% | 1.75% |
| AMERIPRISE FINANCIAL INC | 02/17/2026 | 2.59 M | $42.08 M | -56.61% | 1.71% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 02/13/2026 | 2.42 M | $39.33 M | -0.79% | 1.58% |
| FRED ALGER MANAGEMENT, LLC | 02/17/2026 | 2.25 M | $36.47 M | -10.69% | 1.47% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/17/2026 | 2.17 M | $35.16 M | 332.13% | 1.43% |
| ARK INVESTMENT MANAGEMENT LLC | 02/11/2026 | 2.14 M | $34.74 M | -32.43% | 1.41% |
| NIKKO ASSET MANAGEMENT AMERICAS, INC. | 02/11/2026 | 1.95 M | $31.62 M | -46.64% | 1.28% |
| SUMITOMO MITSUI TRUST HOLDINGS, INC. | 01/23/2026 | 1.95 M | $31.63 M | -46.64% | 1.28% |
| MACQUARIE MANAGEMENT HOLDINGS, INC. | 02/17/2026 | 1.94 M | $31.51 M | 100.00% | 1.27% |
| D. E. SHAW & CO., INC. | 02/17/2026 | 1.90 M | $30.90 M | 157.75% | 1.25% |
| ARISTOTLE ATLANTIC PARTNERS, LLC | 02/17/2026 | 1.84 M | $29.92 M | -41.07% | 1.20% |
| BLUE WATER LIFE SCIENCE ADVISORS, LP | 02/17/2026 | 1.77 M | $28.67 M | -17.71% | 1.16% |
| DEUTSCHE BANK AG\ | 02/11/2026 | 1.73 M | $28.17 M | 1.24% | 1.14% |
| 04/10/2026 | 1.65 M | $26.80 M | 100.00% | 1.08% | |
| PRINCIPAL FINANCIAL GROUP INC | 02/02/2026 | 1.55 M | $25.21 M | 155.20% | 1.02% |
| DIMENSIONAL FUND ADVISORS LP | 02/12/2026 | 1.38 M | $22.46 M | -0.25% | 0.91% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 1.17 M | $19.06 M | 1.82% | 0.77% |
| NORTHERN TRUST CORP | 02/17/2026 | 1.17 M | $19.05 M | -4.79% | 0.77% |
| MORGAN STANLEY | 02/13/2026 | 1.15 M | $18.66 M | 7.18% | 0.75% |
| ABRDN PLC | 01/16/2026 | 1.05 M | $17.00 M | 5.29% | 0.69% |
| NEXT CENTURY GROWTH INVESTORS LLC | 02/13/2026 | 943.60 K | $15.32 M | 77.60% | 0.62% |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 01/22/2026 | 922.50 K | $14.98 M | -25.58% | 0.61% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/17/2026 | 914.16 K | $14.85 M | -4.00% | 0.60% |
| KENNEDY CAPITAL MANAGEMENT LLC | 02/13/2026 | 900.23 K | $14.62 M | -29.32% | 0.59% |
| ALGERT GLOBAL LLC | 02/17/2026 | 884.37 K | $14.36 M | 69.41% | 0.58% |
| CATALIO CAPITAL MANAGEMENT, LP | 02/17/2026 | 821.20 K | $13.34 M | -7.20% | 0.54% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 806.27 K | $13.09 M | -49.54% | 0.53% |
| NUVEEN, LLC | 02/12/2026 | 786.65 K | $12.78 M | -33.13% | 0.51% |
| OBERWEIS ASSET MANAGEMENT INC/ | 02/17/2026 | 744.50 K | $12.09 M | 2.48% | 0.49% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 02/13/2026 | 624.22 K | $10.14 M | -2.23% | 0.41% |
| HILLSDALE INVESTMENT MANAGEMENT INC. | 02/10/2026 | 616.95 K | $10.02 M | -0.78% | 0.41% |
| RHENMAN & PARTNERS ASSET MANAGEMENT AB | 02/13/2026 | 605.00 K | $9.83 M | 22.22% | 0.40% |
| STEMPOINT CAPITAL LP | 02/17/2026 | 606.83 K | $9.85 M | 100.00% | 0.40% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 02/10/2026 | 591.32 K | $9.60 M | 956.99% | 0.39% |
| TUDOR INVESTMENT CORP ET AL | 02/17/2026 | 554.04 K | $9.00 M | -19.28% | 0.37% |
| FIRST TRUST ADVISORS LP | 02/13/2026 | 539.08 K | $8.75 M | -0.75% | 0.35% |
| CERITY PARTNERS LLC | 02/11/2026 | 512.87 K | $8.33 M | 18.57% | 0.34% |
| UBS GROUP AG | 01/29/2026 | 511.93 K | $8.31 M | 101.56% | 0.33% |
| VICTORY CAPITAL MANAGEMENT INC | 02/13/2026 | 487.71 K | $7.92 M | -60.88% | 0.32% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Adaptive Biotechnologies Corp institutional Ownership - FAQ's
During the previous two years, 384 institutional investors and hedge funds held shares of Adaptive Biotechnologies Corp. The most heavily invested institutionals were:
WESTFIELD CAPITAL MANAGEMENT CO LP: 5.44 M
Invesco Ltd.: 4.45 M
ARK Investment Management LLC: 2.09 M
PRINCIPAL FINANCIAL GROUP INC: 1.7 M
Sumitomo Mitsui Trust Holdings, Inc.: 1.6 M
Nikko Asset Management Americas, Inc.: 1.6 M
98.15% of Adaptive Biotechnologies Corp stock is owned by institutional investors.
Institutional investors have bought a total of 174.39 M shares in the last 24 months. This purchase volume represents approximately $2.61 B in transactions.